Goki Suda

3.3k total citations
71 papers, 1.0k citations indexed

About

Goki Suda is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Goki Suda has authored 71 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hepatology, 30 papers in Epidemiology and 17 papers in Molecular Biology. Recurrent topics in Goki Suda's work include Liver Disease Diagnosis and Treatment (26 papers), Hepatitis C virus research (25 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). Goki Suda is often cited by papers focused on Liver Disease Diagnosis and Treatment (26 papers), Hepatitis C virus research (25 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). Goki Suda collaborates with scholars based in Japan, United States and United Kingdom. Goki Suda's co-authors include Naoya Sakamoto, Kenichi Morikawa, Osamu Maehara, Masatsugu Ohara, Koji Ogawa, Shunsuke Ohnishi, Mitsuteru Natsuizaka, Takuya Sho, Masato Nakai and Megumi Kimura and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Goki Suda

63 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Goki Suda Japan 19 475 433 332 162 140 71 1.0k
Qinghua Meng China 19 605 1.3× 734 1.7× 334 1.0× 252 1.6× 94 0.7× 70 1.4k
Sohji Nishina Japan 19 254 0.5× 430 1.0× 329 1.0× 129 0.8× 190 1.4× 36 1.1k
Émilie Crouchet France 10 710 1.5× 727 1.7× 296 0.9× 137 0.8× 77 0.6× 17 1.2k
Cristiana Bulato Italy 20 358 0.8× 329 0.8× 395 1.2× 54 0.3× 183 1.3× 47 1.4k
Pan Zhao China 18 274 0.6× 373 0.9× 438 1.3× 259 1.6× 123 0.9× 64 1.1k
Soon Woo Nam South Korea 20 653 1.4× 575 1.3× 271 0.8× 105 0.6× 324 2.3× 63 1.4k
Nirupama Trehanpati India 15 635 1.3× 618 1.4× 214 0.6× 123 0.8× 93 0.7× 27 1.1k
Tomoko Tadokoro Japan 20 224 0.5× 286 0.7× 400 1.2× 275 1.7× 129 0.9× 74 933
Tatehiro Kagawa Japan 22 576 1.2× 527 1.2× 319 1.0× 95 0.6× 340 2.4× 107 1.4k
Marco Biolato Italy 18 420 0.9× 455 1.1× 135 0.4× 58 0.4× 95 0.7× 50 965

Countries citing papers authored by Goki Suda

Since Specialization
Citations

This map shows the geographic impact of Goki Suda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Goki Suda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Goki Suda more than expected).

Fields of papers citing papers by Goki Suda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Goki Suda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Goki Suda. The network helps show where Goki Suda may publish in the future.

Co-authorship network of co-authors of Goki Suda

This figure shows the co-authorship network connecting the top 25 collaborators of Goki Suda. A scholar is included among the top collaborators of Goki Suda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Goki Suda. Goki Suda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miwa, Takao, Goki Suda, Ryosuke Tateishi, et al.. (2025). Cachexia is an independent predictor of mortality in patients with cirrhosis. Hepatology Research. 55(6). 859–867.
2.
Kudo, Takashi, Daigo Nakazawa, Saori Nishio, et al.. (2024). Tubulointerstitial nephritis with IgM-positive plasma cells complicated by liver failure. CEN Case Reports. 14(2). 253–260.
3.
Ohara, Masatsugu, Goki Suda, Takashi Sasaki, et al.. (2023). Coexistence of muscle atrophy and high subcutaneous adipose tissue radiodensity predicts poor prognosis in hepatocellular carcinoma. Frontiers in Nutrition. 10. 1272728–1272728. 3 indexed citations
4.
Nakai, Masato, Kenichi Morikawa, Takashi Sasaki, et al.. (2023). Neutrophil gelatinase-associated lipocalin predicts the efficacy of tolvaptan for ascites in patients with liver cirrhosis. Journal of Gastroenterology. 58(7). 656–667.
5.
Yang, Zijian, Goki Suda, Osamu Maehara, et al.. (2023). Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma. Cancers. 15(3). 593–593. 8 indexed citations
6.
Rimini, Margherita, Andrea Casadei‐Gardini, Mara Persano, et al.. (2023). Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: A large, real-life, worldwide population.. Journal of Clinical Oncology. 41(4_suppl). 579–579. 4 indexed citations
7.
Nakai, Masato, Goki Suda, Koji Ogawa, et al.. (2022). Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients. PLoS ONE. 17(7). e0270786–e0270786. 5 indexed citations
8.
Suzuki, Kazuharu, Goki Suda, Yoshiya Yamamoto, et al.. (2022). Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B. PLoS ONE. 17(1). e0261760–e0261760. 20 indexed citations
9.
Sho, Takuya, Kenichi Morikawa, Akinori Kubo, et al.. (2021). Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy. World Journal of Gastrointestinal Oncology. 13(12). 2076–2087. 4 indexed citations
10.
11.
Nakai, Masato, Goki Suda, Akinori Kubo, et al.. (2020). Durable response without recurrence to Tolvaptan improves long-term survival. Journal of Gastroenterology. 55(12). 1150–1161. 1 indexed citations
12.
Maehara, Osamu, Shunsuke Ohnishi, Goki Suda, et al.. (2019). Metformin Regulates the Expression of CD133 Through the AMPK-CEBPβ Pathway in Hepatocellular Carcinoma Cell Lines. Neoplasia. 21(6). 545–556. 31 indexed citations
13.
Koch, Benjamin, Kenichi Morikawa, Goki Suda, et al.. (2018). Macrophage-Derived Extracellular Vesicles Induce Long-Lasting Immunity Against Hepatitis C Virus Which Is Blunted by Polyunsaturated Fatty Acids. Frontiers in Immunology. 9. 723–723. 58 indexed citations
14.
Suda, Goki, Koji Ogawa, Kenichi Morikawa, & Naoya Sakamoto. (2018). Treatment of hepatitis C in special populations. Journal of Gastroenterology. 53(5). 591–605. 23 indexed citations
15.
Ohara, Masatsugu, Shunsuke Ohnishi, Hidetaka Hosono, et al.. (2018). Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats. Frontiers in Pharmacology. 9. 709–709. 14 indexed citations
16.
Kawagishi, Naoki, Goki Suda, Akinobu Nakamura, et al.. (2018). Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis. PLoS ONE. 13(12). e0209615–e0209615. 31 indexed citations
17.
Sho, Takuya, Mitsuru Nakanishi, Kenichi Morikawa, et al.. (2017). A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma. Drugs in R&D. 17(3). 381–388. 12 indexed citations
18.
Suda, Goki, Koji Ogawa, Megumi Kimura, et al.. (2016). Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment. Journal of Clinical and Translational Hepatology. 4(4). 320–327. 10 indexed citations
19.
Sato, Fumiyuki, Yoshimasa Kubota, Mitsuteru Natsuizaka, et al.. (2015). EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition. Cancer Biology & Therapy. 16(6). 933–940. 39 indexed citations
20.
Chuma, Makoto, Naoya Sakamoto, Akira Nakai, et al.. (2013). Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor-κB/mitogen-activated protein kinase. Carcinogenesis. 35(2). 272–281. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qinghua Meng Breakdown of academic impact, for papers by Sohji Nishina Breakdown of academic impact, for papers by Émilie Crouchet Breakdown of academic impact, for papers by Cristiana Bulato Breakdown of academic impact, for papers by Pan Zhao Breakdown of academic impact, for papers by Soon Woo Nam Breakdown of academic impact, for papers by Nirupama Trehanpati Breakdown of academic impact, for papers by Tomoko Tadokoro Breakdown of academic impact, for papers by Tatehiro Kagawa Breakdown of academic impact, for papers by Marco Biolato
Rankless by CCL
2026